ArticleCell death & disease2013

PI3K/mTOR pathway inhibitors sensitize chronic myeloid leukemia stem cells to nilotinib and restore the response of progenitors to nilotinib in the presence of stem cell factor.

K Airiau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.